Literature DB >> 26567817

Baseline HV-interval predicts complete AV-block secondary to transcatheter aortic valve implantation.

Dong-In Shin, Marc W Merx, Christian Meyer, Kiriakos Kirmanoglou, Katharina Hellhammer, Jan Ohlig, Dimitra Katsani, Tobias Zeus, Ralf Westenfeld, Christian Eickholt, Axel Linke, Malte Kelm.   

Abstract

PURPOSE: Development of AV-block is a frequent complication associated with transcatheter aortic valve implantation (TAVI). To date little is known about the predictive value of the HV-interval prior to TAVI with respect to the risk of AV-block development. METHODS AND
RESULTS: HV-interval was determined in 25 consecutive elderly patients with severe aortic valve stenosis (AS) before and immediately after TAVI. All patients subsequently underwent TAVI and 8 of these 25 patients (32%) developed complete AV-block during the TAVI procedure requiring permanent pacemaker implantation. Six of these 8 patients (75%) had marked HV prolongation (>54 ms). Pre-procedural HV-interval was significantly prolonged in the subgroup developing complete AV-block (62.1 ms±13.0 vs 49.2 ms±12.9; P=0.029). Prolongation of the HV-interval above 54 ms was associated with a higher rate of complete AV-block (sensitivity 75.0%, specificity 77.8%, P=0.01).
CONCLUSIONS: HV-interval was prolonged in approximately one third of our elderly patients with aortic valve stenosis and associated with a high rate of complete AV-block following TAVI. HV-interval is easily obtained during TAVI screening procedures, thus facilitating identification of patients at risk for complete AV-block due to TAVI and consequently enabling bespoke risk management.

Entities:  

Keywords:  CoreValve; HV-interval; TAVI; aortic valve disease; complete AV-block; permanent pacemaker

Mesh:

Year:  2015        PMID: 26567817     DOI: 10.2143/AC.70.5.3110518

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  1 in total

1.  Prognosis assessment of persistent left bundle branch block after TAVI by an electrophysiological and remote monitoring risk-adapted algorithm: rationale and design of the multicentre LBBB-TAVI Study.

Authors:  Grégoire Massoullié; Pierre Bordachar; Didier Irles; Christophe Caussin; Antoine Da Costa; Pascal Defaye; Frédéric Jean; Alexis Mechulan; Pierre Mondoly; Géraud Souteyrand; Bruno Pereira; Sylvain Ploux; Romain Eschalier
Journal:  BMJ Open       Date:  2016-10-26       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.